Health Sciences Grants

Health Sciences Research Awards and Grants

Title Type $ Amount Activity Investigator Unit Sponsor Date
A First-in-human, Multicenter, Open-label, Dose Escalation and Dose Expansion Phase 1 Study in Patients with Advanced Solid Tumors to Evaluate the Safety of Intravenously Administered ALG.APV-527 Contract 348,649.08 Clinical Trial Jennifer Segar Cancer Center Division Aptevo Therapeutics Inc 04/2024
A Multi-Center, Phase IIA, Randomized, Double-Blind, Prospective, Active Placebo- Controlled Trial of Sub-Anesthetic Intravenous Infusion of Ketamine to Treat Levodopa- Induced Dyskinesia in Subjects Contract 303,564.48 Clinical Trial Scott Sherman Neurology PharmaTher Inc (Canada) 04/2024
A Phase 1/2, Safety Lead-in and Dose Expansion, Open-label, Multicenter Trial Investigating the Safety,Tolerability, and Preliminary Activity of Ivosidenib in Combination with Nivolumab and Ipilimumab Contract 20,590.00 Clinical Trial Rachna Shroff Cancer Center Division Servier Pharmacueticals 04/2024
A Phase 2, multicenter, Open-Label, Long-Term Safety Study of LP352 in Subjects with Developmental and Epileptic Encephalopathy who Completed Study LP352-201 and are Candidates for Continuous Treatmen Contract 19,770.00 Clinical Trial David Labiner Neurology Longboard Pharmaceuticals, Inc. 04/2024
A Phase 2, Randomized, Open-label Study of Onvansertib in Combination with FOLFIRI and Bevacizumab Versus FOLFIRI and Bevacizumab for Second Line Treatment of Metastatic Colorectal Cancer in Patients Contract 23,990.00 Clinical Trial Aaron Scott Cancer Center Division Cardiff Oncology, Inc. 04/2024
A Phase 2/3, Randomized, Double-blind, Placebo-controlled, Parallel-group Study to Evaluate the Efficacy And Safety of Belimumab Administered Subcutaneously in Adults With Systemic Sclerosis Associate Contract 270,564.00 Clinical Trial Sachin Chaudhary Medicine PPD Investigator Services, LLC. 04/2024
A Prospective, Open Label, Single-Arm, Multi-Center Study Evaluating Cryopreserved Osteochondral Allograft Cores for the Treatment Of Osteochondral Lesions in the Knee Contract 179,695.68 Clinical Trial Thomas Carter COM Phx Orthopedics AlloSource 04/2024
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Act Contract 133,337.00 Clinical Trial Sasha Taleban Medicine IQVIA RDS Inc. 04/2024
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled,Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR-MD-02) for the Prevention of Esopha Contract 2,600.00 Clinical Trial Geoffrey Block Liver Research Institute Galectin Therapeutics Inc. 04/2024
Advanced Methods and Software for Trial Sequential Analysis in Living Systematic Reviews Grant 364,114.00 Research Lifeng Lin Epidemiology and Biostatistics National Library of Medicine 04/2024
Biological Function and Regulation of PRMT9 in Synapse Development Grant 128,937.00 Research Shenfeng Qiu COM Phx Basic Medical Sci Beckman Research Institute of The City of Hope 04/2024
Computer Modeling of Myosin Binding Protein C and Its Effects on Cardiac Contraction Grant 126,750.00 Research Brett Colson Cellular & Molecular Medicine Case Western Reserve University 04/2024
Connexins as Potential Biomarkers and Therapeutic Targets for Vascular Malformation Grant 15,299.00 Research Jose Ek Vitorin Physiology University of California, Irvine 04/2024
Deep-Learning Based Pharmacokinetic Model for Vancomycin Grant 29,054.00 Research Bijun Kannadath COM Phx Internal Medicine Houston Methodist Research Institute 04/2024
Developing Personalized Ovarian Cancer Risk Prediction through Circulating miRNA Biomarkers in 'Non-Genetic High-Risk' Women Grant 750,000.00 Research Setsuko Chambers Obstetrics and Gynecology Arizona Biomedical Research Centre 04/2024
Disrupted Lipid Metabolism in Alzheimer's Disease Grant 1,610,885.00 Research Fei Yin UAHS Brain Science National Institute on Aging 04/2024
Diversity in Research Education in Aging Medicine and Science Grant 1,441,340.00 Research Training Kathleen Rodgers UAHS Brain Science National Institute on Aging 04/2024
Elucidating the Role and Therapeutic Vulnerability of Sema5B in RCC Grant 1,075,679.00 Research Anirban Kundu Urology United States Army Medical Research Acquisition Activity 04/2024
Engineering Pluripotent Stem Cells to Evade and Promote Immunity Grant 1,003,738.00 Research Deepta Bhattacharya Immunobiology Mount Sinai School of Medicine 04/2024
Engineering Pluripotent Stem Cells to Promote Immunity Grant 431,543.00 Research Deepta Bhattacharya Immunobiology Bill and Melinda Gates Foundation 04/2024